SCHEMBL27770580

SCHEMBL27770580

CCP(=O)(CC)OC(F)(F)C(F)(F)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
POLB P06746 2/20 0.43
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
ACHE P22303 2/20 0.41
BCHE P06276 1/20 0.41
CA5A P35218 1/20 0.41
CA9 Q16790 1/20 0.41
HSD11B1 P28845 1/20 0.39
HSD17B10 Q99714 2/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
RORC P51449 1/20 0.38
MAPT P10636 3/20 0.37
AKR1C3 P42330 1/20 0.37
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
BCL9 O00512 1/20 0.35
CTNNB1 P35222 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27770581 0.84 PTPRC (0.48) ALDH1A1ACHETSHRMAPTAKR1C3
SCHEMBL10128365 0.77 CA1 (0.43) ALDH1A1POLBCA1CA2ACHE
SCHEMBL27749895 0.75 NPSR1 (0.42) ALDH1A1ACHEHSD17B10TSHRCES2
SCHEMBL643468 0.74 CA1 (0.51) ALDH1A1POLBCA1CA2ACHE
SCHEMBL10155660 0.71 ALDH1A1 (0.40) ALDH1A1POLBCA1CA2ACHE
SCHEMBL643469 0.71 ALDH1A1 (0.40) ALDH1A1POLBCA1CA2ACHE
SCHEMBL27841628 0.71 AKR1C3 (0.66) ALDH1A1CA1CA2ACHEBCHE
SCHEMBL642520 0.71 CA1 (0.54) ALDH1A1POLBCA1CA2ACHE
SCHEMBL4973441 0.70 CA1 (0.56) ALDH1A1CA1CA2ACHECA5A
SCHEMBL445417 0.70 CA1 (0.56) ALDH1A1CA1CA2ACHECA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101501051-A Amides as sphingomyeline inhibitors NOVARTIS AG (CH) 2009-08-05 CN claimed
CN-101501051-A Amides as sphingomyeline inhibitors NOVARTIS AG (CH) 2009-08-05 CN disclosed